DBV Technologies | Ativo Circulante



Current Assets Alterar Data
Acadia Pharmaceuticals USD 960.55M 89.61M 2025-06
Alnylam Pharmaceuticals USD 3.64B 375.44M 2025-06
Amarin USD 573.06M 22.34M 2025-03
BioMarin Pharmaceutical USD 3.81B 337.43M 2025-06
DBV Technologies USD 29.15M 15.24M 2025-03
Halozyme Therapeutics USD 1.12B 139.35M 2025-06
Incyte USD 3.64B 411.91M 2025-06
Insmed USD 2.08B 678.89M 2025-06
Ionis Pharmaceuticals USD 2.58B 158.22M 2025-06
Neurocrine Biosciences USD 1.75B 111M 2025-06
PTC Therapeutics USD 2.27B 43.53M 2025-06
Sarepta Therapeutics USD 2.66B 224.45M 2025-06
Ultragenyx Pharmaceutical USD 719.79M 20.63M 2025-06
United Therapeutics USD 3.83B 112.9M 2025-06


DBV Technologies Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Aug 2025.